Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatments for Diffuse Fibrotic Lung Disease
NCT00000596Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 1978
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of cyclophosphamide, dapsone, methylprednisolone in idiopathic pulmonary fibrosis (IPF), sarcoidosis, sponsored by National Heart, Lung, and Blood Institute. Started Jun 1978; status: completed.
02
Drugs
cyclophosphamidedapsonemethylprednisolone
03
Conditions
idiopathic pulmonary fibrosis (IPF)sarcoidosis
Beyond the preview
Go deeper on NCT00000596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000596.